SEC Form 4 · accession 0000899243-17-011809
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William F Doyle
Officer — Executive Chairman · Director
Period of report
May 2, 2017
Accepted (ET)
May 4, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF1 | $11.85 | May 2, 2017 | A | 881,519 | A | — | May 2, 2027 | Ordinary shares | 881,519 | 881,519 | D |
| Options to Buy Ordinary SharesF2 | $11.85 | May 2, 2017 | A | 881,519 | A | — | May 2, 2027 | Ordinary shares | 881,519 | 881,519 | D |
| Restricted Stock UnitF3,F4 | — | May 2, 2017 | A | 881,519 | A | — | — | Ordinary shares | 881,519 | 881,519 | D |
Explanation of responses
- F1Options to buy 881,519 ordinary shares will fully vest and become exercisable on May 2, 2020 if (i) the closing price of the Company's ordinary shares is at least $14.81 for a period of at least twenty (20) consecutive trading days at any time between May 2, 2017 and May 2, 2020 and (ii) Mr. Doyle has been continuously employed by the Company through May 2, 2020.
- F2Options to buy 881,519 ordinary shares will fully vest and become exercisable on May 2, 2022 if (i) the closing price of the Company's ordinary shares is at least $22.50 for a period of at least twenty (20) consecutive trading days at any time between May 2, 2017 and May 2, 2022 and (ii) Mr. Doyle has been continuously employed by the Company through May 2, 2022.
- F3Each restricted stock unit represents the right to receive, at settlement, one (1) ordinary share.
- F4One-third of these restricted stock units are scheduled to vest on each of May 2, 2018, May 2, 2019, and May 2, 2020, subject to Mr. Doyle's continued employment through such dates.